Nexperia: Why the Dutch Government Seized Control of a Chinese-Owned Chipmaker in 2025

The Nexperia affair is the first time a European government has seized operational control of a Chinese-owned technology company, and it shows how quickly a dispute over corporate governance can turn into a supply-chain crisis for an entire industry. Nexperia makes the cheapest and most ubiquitous chips in a car, the diodes, transistors and logic devices that control windows, wipers and power distribution, and it makes them in volumes of more than 100 billion units a year. When those chips stopped flowing in October 2025, assembly lines in Canada, Mexico, Germany and Japan slowed within weeks. This article explains who Wingtech is, what the Dutch government did and why, how China retaliated, what it cost the auto industry and where the company stands in October 2026. It is part of the Netherlands Company Stories hub.

What is Nexperia and how did a Chinese company come to own it?

Nexperia is the former Standard Products division of NXP Semiconductors, which was itself the former semiconductor arm of Philips. It became an independent company on 6 February 2017 when NXP sold the unit for about US$2.75bn to a consortium led by two Chinese investment firms, JAC Capital and Wise Road Capital, taking roughly 11,000 employees with it. The headquarters stayed in Nijmegen, with front-end wafer fabs in Hamburg and Greater Manchester and back-end assembly in Dongguan in China, Seremban in Malaysia and Cabuyao in the Philippines.

Wingtech Technology, a Shanghai-listed smartphone contract manufacturer founded by Zhang Xuezheng, bought Nexperia from the consortium in a deal completed on 25 October 2018 for about US$3.6bn, making it the largest-ever Chinese acquisition of a European semiconductor company. For Wingtech the purchase was a strategic pivot: contract manufacturing for Xiaomi and Huawei carried thin margins, while discrete semiconductors offered gross margins in the mid-30s and a global automotive customer base. By 2024 the semiconductor unit was the only meaningful part of Wingtech left after it divested most of the ODM business.

Nexperia’s products are unglamorous but essential. The company ships more than 100 billion units a year of diodes, MOSFETs, bipolar transistors, logic chips and protection devices; a modern car can contain several hundred of them. About 60% of revenue comes from automotive customers, and the company’s market position in these commodity parts is strong enough that qualifying an alternative supplier typically takes six to twelve months. The company’s 2022 revenue was about US$2.1bn.

Why did the Dutch government intervene in September 2025?

The government intervened because it believed Zhang was preparing to move technology, production and intellectual property out of Europe into China, and because US sanctions were about to make Nexperia untouchable for Western customers. The decision was taken by caretaker economic affairs minister Vincent Karremans after three of Nexperia’s own European executives, including chief legal officer Ruben Lichtenberg, asked The Hague for help.

The immediate trigger was American. Wingtech had been placed on the US Entity List in December 2024. On 29 September 2025 the US Bureau of Industry and Security extended those controls to any company at least 50% owned by a listed entity, the so-called “Affiliates Rule”, which automatically swept Nexperia into the sanctions net. From that moment, US customers and suppliers would have had to stop dealing with the company unless ownership changed.

Karremans invoked the Goods Availability Act (Wet beschikbaarheid goederen), a 1952 Cold War-era statute that had never been used, on 30 September 2025. The order did not nationalise Nexperia; it froze the company’s ability to change its assets, governance or operations for twelve months without ministerial consent. On 7 October 2025 the Enterprise Chamber of the Amsterdam Court of Appeal, acting ex parte on the executives’ petition, suspended Zhang as CEO and director, transferred all but one of Wingtech’s shares to an independent trustee and appointed a non-Chinese executive with a casting vote. The court cited reckless leadership and valid reasons to doubt proper management; Wingtech denied any plan to strip the company and called the intervention ill-considered. The intervention was made public on 12 October 2025. Nexperia appointed chief financial officer Stefan Tilger as interim CEO.

How did China retaliate, and why did it hurt carmakers so quickly?

China’s Ministry of Commerce banned the export of certain finished components and sub-assemblies from Nexperia’s Chinese operations and their subcontractors on 4 October 2025, four days after the Dutch order. Because the Dongguan facility performs final assembly and testing for roughly 70% of Nexperia’s global volume, the ban cut off most of the company’s finished products even though the wafers were made in Hamburg and Manchester.

The pain reached carmakers within three weeks. On 28 October Honda shut its plant in Celaya, Mexico, and halved output at its Alliston, Ontario, facility, which builds the Civic and CR-V. Volkswagen warned on 30 October that it needed a steady chip supply to hit its 2025 targets and that it could not rule out disruption beyond the following week. Nissan said it had parts until the first week of November; Aumovio, the former Continental parts arm, prepared short-time work at Villingen; the European carmakers’ association ACEA warned of plant stoppages within days; and in the US, Ford’s Jim Farley called the dispute political while GM’s Mary Barra said it could hit production. In December Guangzhou’s GAC Honda joint venture halted lines for two days.

Nexperia’s European headquarters escalated too. On 17 October the Chinese unit said Nijmegen had stopped paying salaries and cut IT access; on 18 October it told staff to ignore the Dutch head office and declared itself an independent Chinese entity; on 29 October Nijmegen suspended wafer shipments to Dongguan, citing a lack of transparency over quality and manufacturing. By the end of October the company was effectively two businesses sharing a name.

How was the acute crisis defused in November 2025?

The crisis eased because it got caught up in a bigger US–China deal. On 30 October 2025 Donald Trump and Xi Jinping met in Busan and agreed a trade truce that included a one-year suspension of the Affiliates Rule, removing the original legal pressure on Nexperia. On 1 November Beijing said it was considering exemptions for civilian-use Nexperia chips, on 6 November it confirmed licence approvals, and by 11 November the first shipments were on their way to Europe.

The Netherlands reciprocated. On 19 November 2025 Karremans suspended the Goods Availability Act order as a show of goodwill; Beijing called it a first step in the right direction. The European Commission said a worst-case scenario had been averted. What was not suspended was the court-ordered governance regime: Zhang remained suspended, the trustee kept the shares and the Dutch executives kept running the European business. Wingtech said on 20 November that it would use every legal means to regain control, and on 26 November it asked the Dutch Supreme Court to review the Enterprise Chamber’s decisions, arguing they had been taken ex parte and under state influence.

The supply chain did not snap back. Shipments from Dongguan resumed on what Dutch reporting described as a drip-feed basis, Nijmegen never restored wafer supply to China, and the Chinese unit started sourcing wafers domestically. The Affiliates Rule suspension is due to expire on 10 November 2026 unless Washington extends it, which gives the whole arrangement a fixed shelf life.

What happened in the Dutch courts in 2026?

On 11 February 2026 the Enterprise Chamber ruled against Wingtech, ordered a formal investigation (enquête) into Nexperia’s governance and kept all the emergency measures in place for the duration of the probe. The court found valid reasons to doubt proper management under the previous regime, pointing to specific actions taken by Wingtech during 2025.

Nexperia said it would fully cooperate and that production continued normally. Wingtech expressed profound disappointment, said it had never been shown evidence justifying the measures, and warned that failing to lift them would endanger the global supply chain. Its shares fell 4.7% on the day of the disclosure. The investigation was expected to take up to six months; as of October 2026 no findings have been published, and the trustee still controls the shares. Wingtech’s separate Supreme Court appeal against the original ex parte decisions has not produced a ruling.

The financial consequences for Wingtech have been severe. In January 2026 it warned of a 2025 net loss of 9–13.5bn yuan driven by impairments on its Nexperia investment; the reported figure was 8.7bn yuan. China Chengxin downgraded its credit rating with a negative outlook. Its auditors issued a qualified opinion because they could not access Nexperia’s overseas financial systems, which puts the Shanghai listing at risk if the scope limitation is not resolved in 2026. Wingtech posted a further 189m yuan loss in the first quarter of 2026.

How has the dispute moved to Chinese courts?

Wingtech opened a second front in May 2026 by suing Nexperia and three of its executives in China under the country’s Anti-Foreign Sanctions Law, seeking restoration of full control and 8bn yuan (about US$1.2bn) in damages. Separately it announced that it would bring investment-treaty arbitration against the Netherlands under the Netherlands–China bilateral investment treaty, seeking more than US$8bn.

In late August 2026 the Dongguan Intermediate People’s Court granted a property-preservation order freezing 2.14bn yuan (US$318m) of assets held by Nexperia and ITEC BV across Dongguan, Shanghai and Wuxi, including equity in four Nexperia subsidiaries. The freeze runs until August 2029 unless lifted. Nexperia said the measures do not affect daily operations because they apply only to Chinese entities that have operated outside its governance since October 2025 and over which it has no control. Chinese lawyers quoted by the South China Morning Post said a settlement could take months while full litigation could take one to three years.

Meanwhile the Chinese unit has gone its own way. Nexperia China announced in June 2026 that its MOSFET and logic supply chains were complete and that independent operations were largely in place; in August it said it would move its entire product line to a domestic 12-inch wafer supplier, breaking the last technical link to the 6- and 8-inch fabs in Hamburg and Manchester. Nijmegen deconsolidated its Chinese entities with effect from 1 October 2025. In practice there are now two Nexperias: a European company with a European supply chain and a Chinese company using the same brand and legacy designs.

How is the European Nexperia performing without China?

The European business has turned out to be more resilient than the October 2025 panic suggested. Nexperia reported first-quarter 2026 revenue of US$300.3m, excluding its Chinese operations, with positive net income and operating cash flow despite supply constraints. Second-quarter revenue rose 18.4% sequentially to US$355.6m with improving profitability, which the company attributed to stabilising supply and strengthening demand, notably from AI infrastructure.

The company is rebuilding its back end outside China. Capacity at Seremban in Malaysia and Cabuyao in the Philippines is being expanded, and on 21 September 2026 Nexperia announced a partnership with Tata Electronics to assemble and test discretes at Tata’s Jagiroad facility in Assam and to prepare MOSFET wafer production at Tata’s new 300mm fab in Dholera, Gujarat. The company says it employs more than 12,500 people across Europe, Asia and the United States, down from around 14,000 before the split.

Interim CEO Stefan Tilger, a German finance executive, has described the results as proof of the business’s resilience, but the company has not published full-year 2025 accounts and has acknowledged that the Chinese unit is beyond its control. For customers the practical question is qualification: automotive suppliers that relied on Dongguan-packaged parts have had to re-qualify Malaysian and Philippine output, a process that typically takes six to twelve months. The episode has also accelerated interest in Europe’s own back-end capacity, a theme that runs through our story on NXP, ASM International and Besi.

What does the case mean for Chinese investment in Europe?

The Nexperia case has become the reference point for how European states will treat Chinese-owned technology assets when Washington turns the screws. It followed the UK’s 2022 order forcing Nexperia to sell Newport Wafer Fab, completed in 2024 with a US$177m sale to Vishay, and Germany’s block on a Chinese purchase of Elmos’s chip fab the same year. But it went further: for the first time, a government took operational control of a functioning company rather than blocking a deal.

Beijing’s reaction, a targeted export ban that hit third-country carmakers, showed that China is prepared to weaponise its role in back-end chip packaging, where it holds a dominant share of global capacity. European policymakers drew the lesson that mature-node chips, not just advanced ones, are a security issue. The European Commission’s Chips Act review in 2026 has leaned on the episode to argue for more assembly and test capacity in Europe.

For Wingtech and other Chinese acquirers, the lesson is harsher. A US$3.6bn investment has been written down, the parent’s listing is under audit threat and the only recourse is litigation in two jurisdictions that may take years. The Dutch government, for its part, has drawn criticism for acting with a 1952 law and no transparent process, and the outcome of the treaty arbitration will matter for how much discretion states retain. The broader de-risking debate across Dutch business is covered in our story on Dutch multinationals’ China exposure, and the equivalent dynamics for Europe’s most strategic chip company are in our piece on ASML and the EUV monopoly.

What can founders and investors learn from Nexperia?

The first lesson is that ownership is only as secure as the political consensus around it. Wingtech acquired Nexperia legally, cleared every review in 2018 and ran the company for seven years, yet lost control in a single day when the US changed a rule and the Dutch government decided it could not afford the consequences. Investors in cross-border technology assets should price the possibility of sovereign intervention, not just regulatory approval.

The second lesson is operational. Nexperia’s model, wafers in Europe and packaging in China, was efficient but created a single point of failure that a trade dispute could exploit. The company is now paying to duplicate back-end capacity in Malaysia, the Philippines and India, which it could have done gradually over the previous five years at far lower cost. Supply-chain resilience is cheaper when it is built before the crisis.

The third lesson concerns governance. The Dutch executives who petitioned the court were not acting as agents of the state; they used ordinary company-law tools to protect what they saw as the company’s interests. Boards of foreign-owned Dutch companies now know that this path exists, and foreign owners know that local management and works councils have real power. For a comparison with how a listed Dutch travel company has handled the regulatory pressure that comes with scale, read our story on Booking.com and Booking Holdings. Readers interested in similar interventions in other markets can visit the UK Company Stories hub, where the Newport Wafer Fab case is examined.

Frequently Asked Questions